Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising
Novo Nordisk has filed a lawsuit against rival Eli Lilly in a U.S. federal court, accusing the American pharmaceutical company of misleading advertising by claiming its weight-loss drugs outperform Novo’s treatments. The lawsuit, filed...
FDA Approves Wearable Version of Sanofi’s Blood Cancer Drug Sarclisa
The U.S. Food and Drug Administration (FDA) has approved a wearable version of Sanofi’s blood cancer drug Sarclisa, marking the first FDA-approved cancer treatment that can be administered through an on-body injector attached to...
FDA Panel to Review Moderna’s Flu Vaccine for Older Adults
The U.S. Food and Drug Administration’s (FDA) independent vaccine advisory panel is set to review and vote on whether the benefits of Moderna’s influenza vaccine, mFlusiva, outweigh its potential risks in older adults. Moderna...
U.S. Hospitals on Alert as Ebola Risk During World Cup Remains Low
Public health experts say the risk of an Ebola-infected traveler arriving in the United States during the 2026 FIFA World Cup is low, but not impossible. With millions of fans expected to travel across...
Some U.S. Employers Plan to End Coverage of Weight-Loss Drugs as Costs Continue to Rise
Large employers in the United States are increasingly reconsidering coverage for GLP-1 weight-loss medications such as Wegovy, Zepbound, and Foundayo as growing demand continues to drive healthcare costs higher. According to recent surveys, around...